Assembly Biosciences, Inc.
ASMB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $95 | $45 | $63 | $1,301 |
| - Cash | $38 | $20 | $52 | $46 |
| + Debt | $3 | $2 | $3 | $6 |
| Enterprise Value | $59 | $28 | $14 | $1,262 |
| Revenue | $29 | $7 | $0 | $6 |
| % Growth | 298.2% | – | -100% | – |
| Gross Profit | $29 | -$42 | -$69 | $6 |
| % Margin | 100% | -582.7% | – | 100% |
| EBITDA | -$45 | -$64 | -$93 | -$91 |
| % Margin | -158.8% | -896.2% | – | -1,448.4% |
| Net Income | -$40 | -$61 | -$93 | -$130 |
| % Margin | -140.9% | -854.8% | – | -2,076.4% |
| EPS Diluted | -6.69 | -13.38 | -22.82 | -36 |
| % Growth | 50% | 41.4% | 36.6% | – |
| Operating Cash Flow | -$51 | $23 | -$84 | -$93 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$3 |
| Free Cash Flow | -$51 | $22 | -$85 | -$96 |